Market Need BrioHealth Solutions is targeting heart failure patients with the BrioVAD LVAS, highlighting a global opportunity to expand chronic mechanical circulatory support use. This presents sales potential with cardiology centers and HF clinics seeking advanced assist devices for eligible patients.

Clinical Momentum Active trial initiation and ongoing innovation signals a growing clinical pipeline. Engage early with institutions participating in the INNOVATE Trial and leverage upcoming data to drive discussions on adoption and pathways for regulatory clearance.

Global Reach Operations in the United States, China, and Europe suggest multi-regional expansion opportunities. Target international hospitals and distributors, emphasizing cross-border support, training, and local reimbursement strategies.

Technological Edge The BrioVAD LVAS emphasizes patient-centric design and advanced rotor technology. Position as a differentiator to HF programs focused on patient quality of life, long-term support, and reduced complications to accelerate adoption.

Strategic Partnerships With a revenue range in the mid tens of millions and a focus on collaboration in med-tech, pursue partnerships with large systems and device distributors, leveraging milestones, clinical outcomes, and marketing synergies to scale the sales footprint.